Innovation for Health - 14 February 2019
Global Investor Forum Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Florian Ludwig

Thuja Capital
Florian Ludwig

Healthcare Investor
Florian Ludwig, Ph.D., is a medical device professional with 20+ years experience in biophysical research and medical device development. He serves as an investment director at Thuja Capital Management, a European healthcare investor focused on bringing meaningful innovation to patients. Structured to invest in innovative medical devices, therapeutics and diagnostics, Thuja Capital invests in disruptive concepts aiming to improve patient outcomes and contribute to a sustainable healthcare system. Thuja currently has over €50 million under management, with active investments in medtech, biotech and nutraceuticals. Prior to joining Thuja Capital, Florian has led and served on innovation and development teams in global organizations (Guidant, Abbott Vascular, Covidien) and in start-ups (Ventrigraft, Ventrica, ROX Medical, Direct Flow Medical). Drawing on a combination of scientific understanding, market insight and direct field experience, Florian has provided leadership to innovative therapy development programs for heart failure, structural heart, cardiovascular, pulmonary and orthopedic indications.

Florian holds a Diplom and a doctorate degree in physics from the Technical University of Munich, Germany, gained in research collaborations with Duke University, USA, and the University of British Columbia, Canada. He is an author on over 40 issued patents.

Thuja Capital

About Thuja Capital
Thuja Capital is an independent venture capital firm investing in early-stage medical product companies in the Netherlands and Belgium. Our focus is on scaleable products meant for diagnosis, cure, care and prevention, that require (clinical) validation to enable a health claim, and that have the potential to improve quality and/or lower healthcare costs. Apart from providing capital, we leverage our network and provide hands-on support to the companies we invest in.

Sponsors & Partners
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
MSD
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Award sponsor
AXON Lawyers
Award sponsor
Genmab
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.